US
State Street SPDR S&P Pharmaceuticals ETF
XPH · Equity
$58.23
-0.26%
Assets
n/a
Expense ratio
0.35%
Holdings
59
1Y return
+48.1%
Forward P/E
n/a
Top 10 holdings
+24.7%
Return and risk
| 1Y total return | +48.1% |
| 3Y total return | +43.8% |
| 5Y total return | +28.3% |
| 3Y CAGR | +12.9% |
| 5Y CAGR | +5.1% |
| Beta | 0.62 |
| RSI | 52.89 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 59 |
| Expense ratio | 0.35% |
| Dividend yield | +0.6% |
| Top 10 holdings | +24.7% |
| Volume | 23.3K |
All ETF indicators
| All Time High | 67.25 |
| All Time High Change | -13.44 |
| All Time High Date | 2015-07-23 |
| All Time Low | 11.68 |
| All Time Low Change | 398.46 |
| All Time Low Date | 2008-10-10 |
| Atr | 1.15 |
| Beta | 0.62 |
| Cagr10y | 4.92 |
| Cagr15y | 7.56 |
| Cagr1y | 48.18 |
| Cagr3y | 12.87 |
| Cagr5y | 5.12 |
| Ch10y | 46.74 |
| Ch15y | 127.74 |
| Ch1m | 4.18 |
| Ch1w | -1.54 |
| Ch1y | 47 |
| Ch3m | 1.41 |
| Ch3y | 38.55 |
| Ch5y | 20.39 |
| Ch6m | 14.03 |
| Ch YTD | 3.93 |
| Close | 58.38 |
| Div CAGR10 | -20.26 |
| Div CAGR3 | -14.97 |
| Div CAGR5 | 8.72 |
| Dividend Growth | -43.44 |
| Dividend Growth Years | 0 |
| Dividend Years | 21 |
| Dividend Yield | 0.64 |
| Dps | 0.37 |
| Ex Div Date | 2026-03-23 |
| High52 | 60.73 |
| High52ch | -4.12 |
| High52 Date | 2026-05-06 |
| Inception Date | 2006-06-19 |
| Isin | US78464A7220 |
| Last Dividend | 0.06 |
| Low52 | 38.95 |
| Low52ch | 49.51 |
| Low52 Date | 2025-05-14 |
| Ma150 | 54.59 |
| Ma150ch | 6.63 |
| Ma20 | 58.31 |
| Ma200 | 52.43 |
| Ma200ch | 11.02 |
| Ma20ch | -0.18 |
| Ma50 | 55.99 |
| Ma50ch | 3.96 |
| Payment Date | 2026-03-25 |
| Payout Frequency | Quarterly |
| Payout Ratio | 9.92 |
| Price Date | 2026-05-12 |
| Rsi | 52.89 |
| Rsi Monthly | 68.76 |
| Rsi Weekly | 60.24 |
| Sharpe Ratio | 1.77 |
| Sortino Ratio | 3.13 |
| Top10holdings | 24.68 |
| Tr10y | 61.6 |
| Tr15y | 198.45 |
| Tr1m | 4.18 |
| Tr1y | 48.14 |
| Tr3m | 1.53 |
| Tr3y | 43.81 |
| Tr5y | 28.34 |
| Tr6m | 14.39 |
| Tr YTD | 4.05 |